Advertisement

Der Orthopäde

, Volume 48, Issue 3, pp 232–238 | Cite as

Primary clear cell sarcoma of the calcaneus

Report of a rare case and review of the literature
  • Zhe Xu
  • Haiqiang Suo
  • Yao Zhang
  • Wei FengEmail author
Originalien

Abstract

Clear cell sarcoma (CCS) is a rare soft tissue tumor derived from neural crest cells. It accounts for 1% of all soft tissue sarcomas and usually involves the tendons and aponeuroses in the distal ends of the extremities. The foot and the ankle are the most common primary sites. A CCS predominantly occurs in young adults and has rarely been reported in children and older people. On magnetic resonance imaging the tumor has a benign appearance. It appears isointense, hypointense or slightly hyperintense on T1-weighted images. A CCS is typically strongly positive for HMB-45, S‑100, melanA, MITF and vimentin on immunohistochemical investigations and exhibits the t(12;22)(q13;q12) translocation on cytogenetic studies. Metastasis occurs mainly to the regional lymph nodes. A tumor size ≥5 cm is invariably associated with a poor prognosis. The main treatment is wide excision but local recurrence and distant metastases are common. This article presents the case of a 61-year-old man with right ankle tenderness and malaise. Ultrasound-guided biopsy and pathological examination were performed and the pathological diagnosis was a CCS. The patient underwent a below-knee amputation and had no local recurrence or metastasis at the 6‑month follow-up.

Keywords

Tumors Recurrence Metastasis Soft tissue neoplasm Case reports 

Abbreviations

ATF1

Activating transcription factor 1

BPA-Fr

P-borono-L-phenylalanine-fructose complex

CCS

Clear cell sarcoma

CK

Cytokeratin

CREB1

cAMP responsive element binding protein 1

EMA

Epithelial membrane antigen

EMPNST

Epithelioid malignant peripheral nerve sheath tumor

EWSR1

Ewing sarcoma breakpoint region 1

HGF/c-MET

Hepatocyte growth factor/Cellular-met

HMB

Human melanoma black

ILP

Isolated limb perfusion

INI-1

Integrase interactor 1

KIT

CD117

LCA

Leukocyte common antigen

MITF

Melanogenesis associated transcription factor

MRI

Magnetic resonance imaging

SyS

Synovial sarcoma

Primäres Klarzellsarkom des Kalkaneus

Bericht eines seltenen Falls und Literaturreview

Zusammenfassung

Das Klarzellensarkom (CCS) ist ein seltener Weichgewebstumor, der sich aus Neuralleistenzellen entwickelt. Es macht 1 % aller Weichgewebssarkome aus, und in der Regel sind die Sehnen und Aponeurosen am distalen Ende der Extremitäten beteiligt. Der Fuß und das Sprunggelenk sind die am häufigsten betroffenen Lokalisationen. Ein CCS kommt überwiegend bei jungen Erwachsenen vor und wurde nur selten bei Kindern oder älteren Menschen berichtet. In der Magnetresonanztomographie (MRT) zeigt der Tumor ein benignes Erscheinungsbild. Er erscheint isointens, hypointens oder leicht hyperintens in der T1-gewichteten Sequenz. In den immunhistologischen Untersuchungen reagiert das CCS typischerweise stark positiv auf HMB-45, S‑100, melanA, MITF und Vimentin und exhibiert die t(12;22)(q13;q12)-Translokation in zytogenetischen Studien. Metastasen kommen hauptsächlich in den regionalen Lymphknoten vor. Eine Tumorgröße von ≥5 cm ist unweigerlich mit einer schlechten Prognose vergesellschaftet. Die Hauptbehandlung ist eine weite Exzision, aber Lokalrezidive und Fernmetastasen treten häufig auf. Dieser Beitrag stellt den Fall eines 61-jährigen Patienten mit Schmerzen am rechten Sprunggelenk und Unwohlsein vor. Eine ultraschallgesteuerte Biopsie sowie eine pathologische Untersuchung wurden durchgeführt; es wurde die pathologische Diagnose eines CCS gestellt. Der Patient unterzog sich einer Amputation unterhalb des Knies und hatte kein Lokalrezidiv oder Metastasen beim 6‑Monats-follow-up.

Schlüsselwörter

Tumor Rezidiv Metastase Weichgewebsneoplasie Fallberichte 

Notes

Acknowledgements

The present study was supported by the Health and Family Planning Commission of Jilin Province (grant number 2015Z031) and the Science and Technology Department of Jilin Province (grant number 20190304039YY).

Compliance with ethical guidelines

Conflict of interest

X. Zhe, S. Haiqiang, Z. Yao and F. Wei declare that they have no competing interests.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For images or other information within the manuscript which identify patients, informed consent was obtained from them and/or their legal guardians.

References

  1. 1.
    Finley JW, Hanypsiak B, McGrath B, Kraybill W, Gibbs JF (2001) Clear cell sarcoma: the Roswell Park experience. J Surg Oncol 77:16–20PubMedGoogle Scholar
  2. 2.
    Enzinger FM (1965) Clear-cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 18:1163–1174PubMedGoogle Scholar
  3. 3.
    Juel J, Ibrahim RM (2017) A case of clear cell sarcoma—a rare malignancy. Int J Surg Case Rep 36:151–154PubMedPubMedCentralGoogle Scholar
  4. 4.
    Jin L, Sui Y, Zhu H, Chen Z, Liu S (2017) Primary mediastinal clear cell sarcoma: a case report and review of the literature. Diagn Pathol 12(1):5PubMedPubMedCentralGoogle Scholar
  5. 5.
    Liu X, Zhang H, Dong Y (2011) Primary clear cell sarcoma of humerus: case report. World J Surg Oncol 9:163PubMedPubMedCentralGoogle Scholar
  6. 6.
    Nakayama S, Yokote T, Iwaki K et al (2012) A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant. BMC Cancer 12:538PubMedPubMedCentralGoogle Scholar
  7. 7.
    Dim DC, Cooley LD, Miranda RN (2007) Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med 131(1):152–156PubMedGoogle Scholar
  8. 8.
    De Beuckeleer LH, De Schepper AM, Vandevenne JE et al (2000) MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review. Skeletal Radiol 29(4):187–195PubMedGoogle Scholar
  9. 9.
    Antonescu CR, Tschernyavsky SJ, Woodruff JM, Jungbluth AA, Brennan MF, Ladanyi M (2002) Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 4(1):44–52PubMedPubMedCentralGoogle Scholar
  10. 10.
    Wang WL, Mayordomo E, Zhang W et al (2009) Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol 22(9):1201–1209PubMedGoogle Scholar
  11. 11.
    Hisaoka M, Ishida T, Kuo TT et al (2008) Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol 32(3):452–460PubMedGoogle Scholar
  12. 12.
    Ito T, Melamed J, Perle MA, Alukal J (2015) Clear cell sarcoma of the penis: a case report. Am J Clin Exp Urol 3(1):43–47PubMedPubMedCentralGoogle Scholar
  13. 13.
    Antonescu CR, Nafa K, Segal NH, Dal Cin P, Ladanyi M (2006) EWS-CREB1: a recurrent variant fusion in clear cell sarcoma—association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 12(18):5356–5362PubMedGoogle Scholar
  14. 14.
    Cornillie J, van Cann T, Wozniak A, Hompes D, Schöffski P (2016) Biology and management of clear cell sarcoma: state of the art and future perspectives. Expert Rev Anticancer Ther 16(8):839–845PubMedGoogle Scholar
  15. 15.
    Ozuguz P, Kocak M, Atasoy P, Vargel I, Cavusoglu T (2014) Clear cell sarcoma. Indian Dermatol Online J 5(4):488–490PubMedPubMedCentralGoogle Scholar
  16. 16.
    Kawai A, Hosono A, Nakayama R et al (2007) Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer 109(1):109–116PubMedGoogle Scholar
  17. 17.
    Choi JH, Gu MJ, Kim MJ et al (2003) Primary clear cell sarcoma of bone. Skeletal Radiol 32(10):598–602PubMedGoogle Scholar
  18. 18.
    Singh M, Ieremia E, Debiec-Rychter M, Connolly G, Calonje JE (2014) Clear cell sarcoma of the tongue. Histopathology 64(5):750–751PubMedGoogle Scholar
  19. 19.
    Mascard E, Gaspar N, Brugières L, Glorion C, Pannier S, Gomez-Brouchet A (2017) Malignant tumours of the foot and ankle. EFORT Open Rev 2(5):261–271PubMedPubMedCentralGoogle Scholar
  20. 20.
    Bianchi G, Charoenlap C, Cocchi S et al (2014) Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli. Eur J Surg Oncol 40(5):505–510PubMedGoogle Scholar
  21. 21.
    Brekke MK, Northcote K, Temple WE (1998) Clear cell sarcoma in the first metatarsal. An unusual case. J Am Podiatr Med Assoc 88(9):457–461PubMedGoogle Scholar
  22. 22.
    Gelczer RK, Wenger DE, Wold LE (1999) Primary clear cell sarcoma of bone: a unique site of origin. Skeletal Radiol 28(4):240–243PubMedGoogle Scholar
  23. 23.
    Lucas DR, Nascimento AG, Sim FH (1992) Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol 16(12):1197–1204PubMedGoogle Scholar
  24. 24.
    Ferrari A, Casanova M, Bisogno G et al (2002) Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer 94(12):3269–3276PubMedGoogle Scholar
  25. 25.
    Malchau SS, Hayden J, Hornicek F, Mankin HJ (2007) Clear cell sarcoma of soft tissues. J Surg Oncol 95(6):519–522PubMedGoogle Scholar
  26. 26.
    Al-Refaie WB, Ali MW, Chu DZ, Paz IB, Blair SL (2004) Clear cell sarcoma in the era of sentinel lymph node mapping. J Surg Oncol 87(3):126–129PubMedGoogle Scholar
  27. 27.
    Smith HG, Hayes AJ (2016) The role of regional chemotherapy in the management of extremity soft tissue malignancies. Eur J Surg Oncol 42(1):7–17PubMedGoogle Scholar
  28. 28.
    Pennacchioli E, Deraco M, Mariani L et al (2007) Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution. Ann Surg Oncol 14(2):553–559PubMedGoogle Scholar
  29. 29.
    Deenik W, Mooi WJ, Rutgers EJ, Peterse JL, Hart AA, Kroon BB (1999) Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases. Cancer 86(6):969–975PubMedGoogle Scholar
  30. 30.
    Andoh T, Fujimoto T, Suzuki M et al (2015) Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: trial using a lung metastasis model of CCS. Appl Radiat Isot 106:195–201PubMedGoogle Scholar
  31. 31.
    Jones RL, Anastasia C, Khin T et al (2011) Chemotherapy in clear cell sarcoma. Med Oncol 28(3):859–863PubMedGoogle Scholar
  32. 32.
    Karita M, Tsuchiya H, Yamamoto N, Shirai T, Hayashi K, Nishida H (2013) Caffeine-potentiated chemotherapy for clear cell sarcoma: a report of five cases. Int J Clin Oncol 18(1):33–37PubMedGoogle Scholar
  33. 33.
    Mir O, Boudou-Rouquette P, Larousserie F et al (2012) Objective response to sorafenib in advanced clear-cell sarcoma. Ann Oncol 23(3):807–809PubMedGoogle Scholar
  34. 34.
    Stacchiotti S, Grosso F, Negri T et al (2010) Tumor response to sunitinib malate observed in clear-cell sarcoma. Ann Oncol 21(5):1130–1131PubMedGoogle Scholar
  35. 35.
    Outani H, Tanaka T, Wakamatsu T et al (2014) Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS. BMC Cancer 14:455PubMedPubMedCentralGoogle Scholar
  36. 36.
    Licata L, Fenga D, Speciale G, Rosa MA (2014) Clear cell sarcoma of metatarsus. Folia Med (plovdiv) 56(4):271–274Google Scholar
  37. 37.
    Kazakos CJ, Galanis VG, Giatromanolaki A, Verettas DA, Sivridis E (2006) Clear cell sarcoma of the scapula. A case report and review of the literature. World J Surg Oncol 7;4:48Google Scholar
  38. 38.
    Zhang W, Shen Y, Wan R, Zhu Y (2011) Primary clear cell sarcoma of the sacrum: a case report. Skeletal Radiol 40(5):633–639PubMedGoogle Scholar
  39. 39.
    Yokoyama R, Mukai K, Hirota T, Beppu Y, Fukuma H (1996) Primary malignant melanoma (clear cell sarcoma) of bone: report of a case arising in the ulna. Cancer 77(12):2471–2475PubMedGoogle Scholar
  40. 40.
    Hersekli MA, Ozkoc G, Bircan S et al (2005) Primary clear cell sarcoma of rib. Skeletal Radiol 34(3):167–170PubMedGoogle Scholar
  41. 41.
    Rocco G, de Chiara AR, Fazioli F et al (2009) Primary giant clear cell sarcoma (soft tissue malignant melanoma) of the sternum. Ann Thorac Surg 87(6):1927–1928PubMedGoogle Scholar
  42. 42.
    Inaoka T, Takahashi K, Tandai S et al (2003) Primary clear cell sarcoma (malignant melanoma) in the right radius. Skelet Radiol 32(10):594–597Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Bone and JointThe First Hospital of Jilin UniversityChangchun, JilinChina

Personalised recommendations